Used in immunological research to quantify terminal complement complex (SC5b-9) levels in biological samples, this ELISA kit enables assessment of complement system activation. It is particularly valuable in studies related to inflammation, autoimmune diseases, and tissue damage, where uncontrolled complement activation plays a key role. Researchers use it to monitor disease progression in conditions such as sepsis, lupus, and age-related macular degeneration. The assay supports investigation into therapeutic interventions targeting the complement pathway by providing a reliable measure of pathway activity in serum, plasma, or other bodily fluids.